Advertisement

Topics

Goldman , Sachs & Co. Company Profile

02:11 EST 17th December 2018 | BioPortfolio

Goldman Sachs is a leading global investment banking, securities and investment management firm. However, to our clients and those associated with us, we are much more than that. To get a better understanding of who we are, you should get to know our people.
Our Leaders section looks at the people who will continue to develop and lead successful strategies and executions for our clients.

Location

One New York Plaza, 37 th Floor
New York
New York
10004
United States of America


News Articles [285 Associated News Articles listed on BioPortfolio]

Goldman Sachs: Vor der Super-Wende?

Goldman Sachs gehört zu den wenigen Unternehmen der US-Finanzbranche, die seit dem Wahlsieg Trumps im November 2016 nur relativ wenig zugelegt haben. Das dürfte auch daran liegen, dass Goldman Sach....

Goldman Sachs: Sell-Off bei Lithium übertrieben

Der Ausverkauf bei Lithium-Aktien in diesem Jahr ist nach Ansicht von Goldman Sachs "überzogen", schreibt die Financial Times in ihrer gestrigen Ausgabe. Goldman ist selbst einer der größten Rohsto...

Goldman: Euroraum-Kerninflation wird niedrig bleiben: Laut Goldman Sachs werde die EZB zudem 2019 mit ...

Laut Goldman Sachs werde die EZB zudem 2019 mit der Anhebung der Zinsen beginnen und auch den Banken langfristige Kredite anbieten.Die Schwäche der Kerninflation im Euroraum wird laut Goldman Sachs.....

Goldman Sachs gewinnt erste Kunden für Bitcoin-Handelsprodukt

Goldman Sachs hat leise damit begonnen, Kunden für sein kommendes Bitcoin-Handelsprodukt zu gewinnen. TOP-Meldung Goldman Sachs gewinnt erste Kunden für sein Bitcoin-Handelsprodukt Goldman Sachs ha....

ANALYSE-FLASH: Goldman belässt Gerresheimer auf 'Neutral' - Ziel 70 Euro

Die US-Investmentbank Goldman Sachs hat die Einstufung für Gerresheimer auf "Neutral" mit einem Kursziel von 70 Euro belassen. Auf der jährlichen Goldman Sachs Global Healthcare Conference habe si.....

Goldman belässt Gerresheimer auf 'Neutral' - Ziel 70 Euro

Die US-Investmentbank Goldman Sachs hat die Einstufung für Gerresheimer auf "Neutral" mit einem Kursziel von 70 Euro belassen. Auf der jährlichen Goldman Sachs Global Healthcare Conference habe si.....

Ocado shares jump as Goldman Sachs calls its deal with Kroger ‘transformational’

Goldman Sachs upgraded Ocado’s rating to ‘buy’ from ‘neutral’ and set its price target at 1,160p

Goldman Sachs führt das Ranking bei M&A-Transaktionen mit deutscher Beteiligung an

Toronto (www.aktiencheck.de) - Mit der Beratung bei zwölf Transaktionen im Wert von insgesamt USD 138,8 Milliarden ist Goldman Sachs im bisherigen Jahresverlauf 2018 der führende Berater bei Deals ....

Drugs and Medications [0 Results]

None

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Julius Sachs (1868): The father of plant physiology.

The year 2018 marks the 150th anniversary of the first publication of Julius von Sachs' (1832-1897) Lehrbuch der Botanik (Textbook of Botany), which provided a comprehensive summary of what was then k...

Isolated arthroscopic Bankart repair vs Bankart repair with remplissage for anterior shoulder instability with engaging Hill Sachs lesion: a meta-analysis.

Arthroscopic remplissage of a Hill-Sachs lesion (HSL) associated with a Bankart repair (BR) has been recently introduced as a surgical option to treat chronic anterior shoulder instability. The purpos...

Comment on Tamagawa and Ikeda's reinterpretation of the Goldman-Hodgkin-Katz equation : Are transmembrane potentials caused by polarization?

Tay-Sachs Disease Presenting as Refractory Epilepsy with Autistic Regression Secondary to a Novel Mutation in HEXA Gene.

Management of Recurrent Anterior Shoulder Instability With Bipolar Bone Loss: A Systematic Review to Assess Critical Bone Loss Amounts.

There is increasing evidence to suggest that the amount of glenoid bone loss to indicate bone block procedures may be lower than previously thought, particularly in the presence of a Hill-Sachs defect...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

Assessment of Weber Humeral Derotational Osteotomy Using CT Scan

Subjects who have had the Weber osteotomy for Hill-Sachs lesions will have CT of Both shoulders. Amount of rotation in operative shoulder will be compared to contralateral. QOL will be a...

N-Acetyl-L-Leucine for GM2 Gangliosdisosis (Tay-Sachs and Sandhoff Disease)

This is a multinational, multicenter, open-label, rater-blinded prospective Phase II study which will assess the safety and efficacy of N-Acetyl-L-Leucine (IB1001) for the treatment of GM2...

A Phase I Study of Pyrimethamine in Patients With GM-2 Gangliosidosis

Adult Tay-Sachs disease and Sandhoff diseases are caused by deficiency of an enzyme called β-hexosaminidase A, or Hex A in short. This enzyme is located in a particular cellular componen...

Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses

We want to see if Zavesca (or miglustat) is safe and can be tolerated by patients with acute infantile onset GM2 gangliosidosis - classical Tay-Sachs and infantile onset Sandhoff disease. ...

Liq-NOL Efficacy in Pediatric Patients With Down Syndrome

The purpose of this study is to measure the effects of LiQ-NOL supplementation on language production using the Clinical Evaluation of Language Fundamentals test, language sampling using t...

Companies [26 Associated Companies listed on BioPortfolio]

Goldman , Sachs & Co.

Goldman Sachs is a leading global investment banking, securities and investment management firm. However, to our clients and those associated with us, we are much more than that. To get a better under...

Goldman Sachs Group, Inc.

The Goldman Sachs Group, Inc.

Medfinders, Inc.

Medfinders Inc., based in Arlington, TX, provides nursing, allied healthcare and physician placement services through its Nursefinders, Nursefinders Travel, Club Staffing, Nationa...

GS Capital Partners

Since 1986, the Goldman Sachs Merchant Banking Division and its predecessor business areas have raised 16 private equity and principal debt investment funds aggregating over $82 b...

More Information about "Goldman , Sachs & Co." on BioPortfolio

We have published hundreds of Goldman , Sachs & Co. news stories on BioPortfolio along with dozens of Goldman , Sachs & Co. Clinical Trials and PubMed Articles about Goldman , Sachs & Co. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Goldman , Sachs & Co. Companies in our database. You can also find out about relevant Goldman , Sachs & Co. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record